Your AI-Trained Oncology Knowledge Connection!

Larry L. Kestin, MD

home / authors / larry-l-kestin-md

Articles

ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non–Small-Cell Lung Cancer: Good Performance Status/Definitive Intent

Joe Yujiao Chang, MD, PhD;Larry L. Kestin, MD;R. Bryan Barriger, MD;Indrin J. Chetty, PhD;Mark E. Ginsburg, MD;Sanath Kumar, MD;Billy W. Loo, Jr, MD, PhD;Benjamin Movsas, MD;Andreas Rimner, MD;Kenneth E. Rosenzweig, MD;Thomas E. Stinchcombe, MD;Gregory M. M. Videtic, MD, CM;Henning Willers, MD

August 15th 2014

The treatment of inoperable stage III non–small-cell lung cancer (NSCLC) remains a challenge due to high rates of distant metastasis, local recurrence, and toxicity associated with definitive therapy.

Brachytherapy Boost Techniques for Locally Advanced Prostate Cancer

Frank A. Vicini, MD;Larry L. Kestin, MD;Alvaro A. Martinez, MD

April 1st 1999

Brachytherapy boosts in combination with external-beam radiation therapy allow a highly conformal dose of radiation to be delivered to the prostate in a safe, efficient manner. Several types of brachytherapy boost